טוען...
A meta-analysis of the comparing of the first-generation and next-generation TKIs in the treatment of NSCLC
BackgroundThe current standard approach to the treatment of patients with non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)—sensitizing mutations has been the treatment with a first-generation EGFR-TKIs. While, with resistance develope...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AIMS Press
2019-06-01
|
| סדרה: | Mathematical Biosciences and Engineering |
| נושאים: | |
| גישה מקוונת: | https://www.aimspress.com/article/10.3934/mbe.2019283?viewType=HTML |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|